These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8785523)

  • 1. The concentrations of AcSDKP, a physiological inhibitor of cell proliferation, vary during oogenesis and early development in Xenopus laevis.
    Volkov L; Comte L; Frindel E; Philippe M; Praloran V
    Biol Cell; 1995; 85(2-3):223-5. PubMed ID: 8785523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tetrapeptide AcSDKP, a physiological inhibitor of normal cell proliferation, reduces the S phase entry of continuous cell lines.
    Volkov L; Quéré P; Coudert F; Comte L; Praloran V
    Exp Cell Res; 1996 Feb; 223(1):112-6. PubMed ID: 8635482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD; Yan Y; Ewel C; Talmadge JE
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the role of negative regulator, AcSer-Asp-Lys-Pro (AcSDKP) in the phenomena of cellular proliferation].
    Volkov L; Pradelles P; Comte L; Frindel E
    C R Acad Sci III; 1992; 315(12):499-504. PubMed ID: 1297528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tetrapeptide AcSDKP, a negative regulator of cell cycle entry, inhibits the proliferation of human and chicken lymphocytes.
    Volkov L; Quéré P; Coudert F; Comte L; Antipov Y; Praloran V
    Cell Immunol; 1996 Mar; 168(2):302-6. PubMed ID: 8640879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens.
    Comte L; Lorgeot V; Volkov L; Roullet B; Tubiana N; Praloran V
    Cancer Lett; 1997 Jan; 112(1):1-4. PubMed ID: 9029162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow cultures.
    Jackson JD; Ozerol E; Yan Y; Ewel C; Talmadge JE
    J Hematother Stem Cell Res; 2000 Aug; 9(4):489-96. PubMed ID: 10982247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular specificity of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation.
    Robinson S; Lenfant M; Wdzieczak-Bakala J; Riches A
    Stem Cells; 1993 Sep; 11(5):422-7. PubMed ID: 8241953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP.
    Guigon M; Bonnet D; Lemoine F; Kobari L; Parmentier C; Mary JY; Najman A
    Exp Hematol; 1990 Nov; 18(10):1112-5. PubMed ID: 2209766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats.
    Junot C; Nicolet L; Ezan E; Gonzales MF; Menard J; Azizi M
    J Pharmacol Exp Ther; 1999 Dec; 291(3):982-7. PubMed ID: 10565814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo.
    Aidoudi S; Guigon M; Drouet V; Caen JP; Han ZC
    Int J Hematol; 1998 Aug; 68(2):145-55. PubMed ID: 9803673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic mice.
    Wdzieczak-Bakala J; Grillon C; Robinson S; Riches A; Carde P; Lenfant M
    Bull Cancer; 1993 May; 80(5):391-6. PubMed ID: 8173192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. II. Unresponsiveness of isolated adult rat hepatocytes, 3T3, FDC-P2, and K562 cell lines to AcSDKP. Possible involvement of intermediary cell(s) in the mechanism of AcSDKP action.
    Lauret E; Dumenil D; Miyanomae T; Sainteny F
    Exp Hematol; 1989 Dec; 17(11):1081-5. PubMed ID: 2583252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations.
    Comte L; Lorgeot V; Volkov L; Allegraud A; Aldigier JC; Praloran V
    Eur J Clin Invest; 1997 Sep; 27(9):788-90. PubMed ID: 9352252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis.
    Murphy CR; Sabel JL; Sandler AD; Dagle JM
    Dev Dyn; 2002 Dec; 225(4):597-601. PubMed ID: 12454937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiproliferative activity of the tetrapeptide Acetyl-N-SerAspLysPro, an inhibitor of haematopoietic stem cell proliferation, is not mediated by a thymosin beta 4-like effect on actin assembly.
    Cheviron N; Grillon C; Carlier MF; Wdzieczak-Bakala J
    Cell Prolif; 1996 Aug; 29(8):437-46. PubMed ID: 8918557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catabolism of the hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro: a new insight into the physiological role of the angiotensin-I-converting enzyme N-active site.
    Rousseau-Plasse A; Lenfant M; Potier P
    Bioorg Med Chem; 1996 Jul; 4(7):1113-9. PubMed ID: 8831983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation.
    Robinson S; Lenfant M; Wdzieczak-Bakala J; Melville J; Riches A
    Cell Prolif; 1992 Nov; 25(6):623-32. PubMed ID: 1457609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells.
    Bonnet D; Césaire R; Lemoine F; Aoudjhane M; Najman A; Guigon M
    Exp Hematol; 1992 Feb; 20(2):251-5. PubMed ID: 1544396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct stress-inducible and developmentally regulated heat shock transcription factors in Xenopus oocytes.
    Gordon S; Bharadwaj S; Hnatov A; Ali A; Ovsenek N
    Dev Biol; 1997 Jan; 181(1):47-63. PubMed ID: 9015264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.